{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:22:33Z","timestamp":1782706953362,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1124\/jpet.104.066365","type":"journal-article","created":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T22:43:03Z","timestamp":1090017783000},"page":"687-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A\/2C Agonism"],"prefix":"10.1016","volume":"310","author":[{"given":"Christopher","family":"Bishop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Tessmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.066365_bib1","doi-asserted-by":"crossref","unstructured":"Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, and De Souza EB (1990) Autoradiographic characterization of (\u00b1)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1C receptors in rat brain. J Pharmacol Exp Ther 255: 843-857.","DOI":"10.1016\/S0022-3565(25)23167-6"},{"key":"10.1124\/jpet.104.066365_bib2","doi-asserted-by":"crossref","unstructured":"Basura GJ and Walker PD (1999) Serotonin 2A receptor mRNA levels in the neonatal dopamine-depleted rat striatum remain upregulated following suppression of serotonin hyperinnervation. Dev Brain Res 116: 111-117.","DOI":"10.1016\/S0165-3806(99)00066-8"},{"key":"10.1124\/jpet.104.066365_bib3","doi-asserted-by":"crossref","unstructured":"Basura GJ and Walker PD (2000) Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression. Mol Brain Res 81: 80-91.","DOI":"10.1016\/S0169-328X(00)00153-4"},{"key":"10.1124\/jpet.104.066365_bib4","doi-asserted-by":"crossref","unstructured":"Basura GJ and Walker PD (2001) Serotonin2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion. Mol Brain Res 92: 66-77.","DOI":"10.1016\/S0169-328X(01)00151-6"},{"key":"10.1124\/jpet.104.066365_bib5","doi-asserted-by":"crossref","unstructured":"Berger TW, Kaul S, Stricker EM, and Zigmond MJ (1985) Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res 336: 354-358.","DOI":"10.1016\/0006-8993(85)90667-5"},{"key":"10.1124\/jpet.104.066365_bib6","doi-asserted-by":"crossref","unstructured":"Bishop C, Kamdar DP, and Walker PD (2003) Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats. Synapse 50: 164-170.","DOI":"10.1002\/syn.10253"},{"key":"10.1124\/jpet.104.066365_bib7","doi-asserted-by":"crossref","unstructured":"Bishop C and Walker PD (2003) Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats. Neuroscience 121: 649-657.","DOI":"10.1016\/S0306-4522(03)00516-5"},{"key":"10.1124\/jpet.104.066365_bib8","doi-asserted-by":"crossref","unstructured":"Bonhaus DW, Weinhardt KK, Taylor M, Desouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, et al. (1997) RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36: 621-629.","DOI":"10.1016\/S0028-3908(97)00049-X"},{"key":"10.1124\/jpet.104.066365_bib9","doi-asserted-by":"crossref","unstructured":"Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, and Mueller RA (1984) Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 231: 343-354.","DOI":"10.1016\/S0022-3565(25)21630-5"},{"key":"10.1124\/jpet.104.066365_bib10","doi-asserted-by":"crossref","unstructured":"Campbell BM, Gresch PJ, and Walker PD (2001) Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum. Neuroscience 105: 671-680.","DOI":"10.1016\/S0306-4522(01)00218-4"},{"key":"10.1124\/jpet.104.066365_bib11","doi-asserted-by":"crossref","unstructured":"Darmani NA, Martin BR, and Glennon RA (1992) Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (\u00b1)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin. J Pharmacol Exp Ther 262: 692-698.","DOI":"10.1016\/S0022-3565(25)10813-6"},{"key":"10.1124\/jpet.104.066365_bib12","doi-asserted-by":"crossref","unstructured":"Descarries L, Soghomonian JJ, Garcia S, Doucet G, and Bruno JP (1992) Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res 569: 1-13.","DOI":"10.1016\/0006-8993(92)90363-E"},{"key":"10.1124\/jpet.104.066365_bib13","doi-asserted-by":"crossref","unstructured":"Filip M and Cunningham KA (2002) Serotonin 5-HT2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 71: 745-756.","DOI":"10.1016\/S0091-3057(01)00741-9"},{"key":"10.1124\/jpet.104.066365_bib14","doi-asserted-by":"crossref","unstructured":"Fox SH, Moser B, and Brotchie JM (1998) Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson\u2019s disease. Exp Neurol 151: 35-49.","DOI":"10.1006\/exnr.1998.6792"},{"key":"10.1124\/jpet.104.066365_bib15","doi-asserted-by":"crossref","unstructured":"Gresch PJ and Walker PD (1999) Serotonin-2 receptor stimulation normalizes striatal preprotachykinin mRNA in an animal model of Parkinson\u2019s disease. Neuroscience 93: 831-841.","DOI":"10.1016\/S0306-4522(99)00238-9"},{"key":"10.1124\/jpet.104.066365_bib16","doi-asserted-by":"crossref","unstructured":"Jackson D and Abercrombie ED (1992) In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy. J Neurochem 58: 890-897.","DOI":"10.1111\/j.1471-4159.1992.tb09340.x"},{"key":"10.1124\/jpet.104.066365_bib17","doi-asserted-by":"crossref","unstructured":"Jerman JC, Brough SJ, Gager T, Wood M, Coldwell MC, Smart D, and Middlemiss DN (2001) Pharmacological characterization of human 5-HT2 receptor subtypes. Eur J Pharmacol 414: 23-30.","DOI":"10.1016\/S0014-2999(01)00775-0"},{"key":"10.1124\/jpet.104.066365_bib18","doi-asserted-by":"crossref","unstructured":"Johnson MP, Siegel BW, and Carr AA (1996) [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand. Naunyn Schmiedebergs Arch Pharmacol 354: 205-209.","DOI":"10.1007\/BF00178722"},{"key":"10.1124\/jpet.104.066365_bib19","doi-asserted-by":"crossref","unstructured":"Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, Frank RA, Van Giersbergen PLM, McCloskey TC, Johnson MP, et al. (1996) Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277: 968-981.","DOI":"10.1016\/S0022-3565(25)12956-X"},{"key":"10.1124\/jpet.104.066365_bib20","doi-asserted-by":"crossref","unstructured":"Koskinen T, Ruotsalainen S, and Sirvio J (2000) The 5-HT2 receptor activation enhances impulsive responding without increasing motor activity in rats. Pharmacol Biochem Behav 66: 729-738.","DOI":"10.1016\/S0091-3057(00)00241-0"},{"key":"10.1124\/jpet.104.066365_bib21","doi-asserted-by":"crossref","unstructured":"Laprade N, Radja F, Reader TA, and Soghomonian JJ (1996) Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons. J Neurosci 16: 3727-3736.","DOI":"10.1523\/JNEUROSCI.16-11-03727.1996"},{"key":"10.1124\/jpet.104.066365_bib22","doi-asserted-by":"crossref","unstructured":"Leysen JE, Niemegeers CJE, Van Nueten JM, and Laduron PM (1982) [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites: binding properties, brain distribution and functional role. Mol Pharmacol 21: 301-314.","DOI":"10.1016\/S0026-895X(25)14623-3"},{"key":"10.1124\/jpet.104.066365_bib23","doi-asserted-by":"crossref","unstructured":"Lopez-Gimenez JF, Mengod G, Palacios JM, and Vilaro MT (1999) Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907, [125I](\u00b1)DOI and [3H]ketanserin. Eur J Neurosci 11: 3761-3765.","DOI":"10.1046\/j.1460-9568.1999.00827.x"},{"key":"10.1124\/jpet.104.066365_bib24","doi-asserted-by":"crossref","unstructured":"Luthman J, Bolioli B, Tsutsumi T, Vershofstad A, and Jonsson G (1987) Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res Bull 19: 269-274.","DOI":"10.1016\/0361-9230(87)90092-X"},{"key":"10.1124\/jpet.104.066365_bib25","doi-asserted-by":"crossref","unstructured":"Luthman J, Fredriksson A, Plaznik A, and Archer T (1991) Ketanserin and mianserin treatment reverses hyperactivity in neonatally dopamine-lesioned rats. J Psychopharmacol 5: 418-425.","DOI":"10.1177\/026988119100500437"},{"key":"10.1124\/jpet.104.066365_bib26","doi-asserted-by":"crossref","unstructured":"McMahon LR, Filip M, and Cunningham KA (2001) Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Neurosci 21: 7781-7787.","DOI":"10.1523\/JNEUROSCI.21-19-07781.2001"},{"key":"10.1124\/jpet.104.066365_bib27","doi-asserted-by":"crossref","unstructured":"McKenna DJ, Nazarali AJ, Hoffman AJ, Nichols DE, Mathis CA, and Saavedra JM (1989) Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]-LSD and [125I]-DOI, a new psychotomimetic radioligand. Brain Res 476: 45-56.","DOI":"10.1016\/0006-8993(89)91535-7"},{"key":"10.1124\/jpet.104.066365_bib28","doi-asserted-by":"crossref","unstructured":"Molina-Holgado E, Dewar KM, Descarries L, and Reader TA (1994) Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J Pharmacol Exp Ther 270: 713-721.","DOI":"10.1016\/S0022-3565(25)22430-2"},{"key":"10.1124\/jpet.104.066365_bib29","doi-asserted-by":"crossref","unstructured":"Mrini A, Soucy J-P, Lafaille F, Lemoine P, and Descarries L (1995) Quantification of the serotonin hyperinnervation in adult rat neostriatum after neonatal 6-hydroxydopamine lesion of nigral dopamine neurons. Brain Res 669: 303-308.","DOI":"10.1016\/0006-8993(94)01210-9"},{"key":"10.1124\/jpet.104.066365_bib30","doi-asserted-by":"crossref","unstructured":"O\u2019Neill MF, Heron-Maxwell CL, and Shaw G (1999) 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine and MK-801 but not D1 agonist C-APB. Pharmacol Biochem Behav 63: 237-243.","DOI":"10.1016\/S0091-3057(98)00240-8"},{"key":"10.1124\/jpet.104.066365_bib31","unstructured":"Paxinos G and Watson C (1998) The Rat Brain in Stereotaxic Coordinates, 4th ed, Academic Press, San Diego, CA."},{"key":"10.1124\/jpet.104.066365_bib32","doi-asserted-by":"crossref","unstructured":"Radja F, Descarries L, Dewar KM, and Reader TA (1993) Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study. Brain Res 606: 273-285.","DOI":"10.1016\/0006-8993(93)90995-Y"},{"key":"10.1124\/jpet.104.066365_bib33","doi-asserted-by":"crossref","unstructured":"Snyder AM, Zigmond MJ, and Lund RD (1986) Sprouting of serotonergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol 245: 274-281.","DOI":"10.1002\/cne.902450209"},{"key":"10.1124\/jpet.104.066365_bib34","doi-asserted-by":"crossref","unstructured":"Stachowiak MK, Bruno JP, Snyder AM, Stricker EM, and Zigmond MJ (1984) Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res 291: 164-167.","DOI":"10.1016\/0006-8993(84)90665-6"},{"key":"10.1124\/jpet.104.066365_bib35","doi-asserted-by":"crossref","unstructured":"Towle AC, Criswell HE, Maynard EH, Lauder JM, Loh TH, Mueller RA, and Breese G (1989) Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study. Pharmacol Biochem Behav 34: 367-374.","DOI":"10.1016\/0091-3057(89)90328-6"},{"key":"10.1124\/jpet.104.066365_bib36","doi-asserted-by":"crossref","unstructured":"Ullrich T and Rice KC (2000) A practical synthesis of the serotonin 5-HT2A receptor antagonist MDL 100907, its enantiomer and their 3-phenolic derivatives as precursors for [11C]labeled PET ligands. Bioorganic Med Chem 8: 2427-2432.","DOI":"10.1016\/S0968-0896(00)00175-9"},{"key":"10.1124\/jpet.104.066365_bib37","doi-asserted-by":"crossref","unstructured":"Waeber C and Palacios JM (1994) Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. Mol Brain Res 24: 199-209.","DOI":"10.1016\/0169-328X(94)90133-3"},{"key":"10.1124\/jpet.104.066365_bib38","doi-asserted-by":"crossref","unstructured":"Walker PD, Capodilupo JG, Wolf WA, and Carlock LR (1996) Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission. Brain Res 732: 25-35.","DOI":"10.1016\/0006-8993(96)00483-0"},{"key":"10.1124\/jpet.104.066365_bib39","doi-asserted-by":"crossref","unstructured":"Willins DL and Meltzer HY (1997) Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282: 699-706.","DOI":"10.1016\/S0022-3565(24)36840-5"},{"key":"10.1124\/jpet.104.066365_bib40","doi-asserted-by":"crossref","unstructured":"Wolf WA and Schutz LJ (1997) The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis. J Neurochem 69: 1449-1458.","DOI":"10.1046\/j.1471-4159.1997.69041449.x"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.066365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:57:16Z","timestamp":1739998636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524314867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0022356524314867"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.066365","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A\/2C Agonism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.066365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}